Search | IOVS | ARVO Journals

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Treatment switch from aflibercept to ranibizumab pre-filled syringe in Canadian DME patients in a real-world setting: The PRECISE study

Michel Giunta; Ananda Kalevar; Pierre Trottier; Louis Caron; Sohel Somani; Raman Tuli; Ghassan Cordahi; Joanne Gavalakis; Eser Adiguzel

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):440. doi:

ARVO Annual Meeting Abstract July 2018

Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: CANTREAT Study One Year Results

Peter Kertes; Tom Sheidow; Geoff Williams; Mark Greve; Ivan John Galic; Emmanouil Rampakakis; Joanne Gavalakis; Andrea Scarino

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1622. doi:

ARVO Annual Meeting Abstract June 2017

Canadian Treat and Extend Analysis Trial with Ranibizumab in Patients with Neovascular AMD: Interim Analysis of the CANTREAT Study

Peter Kertes; Thomas G Sheidow; Geoff Williams; Mark Greve; Ivan Galic; Emmanouil Rampakakis; Joanne Gavalakis; Andrea Scarino

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1200. doi:

Advertisement